期刊文献+

Antitumor Comparison of Three α-N-Heterocyclic Thiosemicarbazone Derivatives' Crystal Structures of Bis(2-acetylpyridine)thiocarbonohydrazone and Bis(imidazole-2-carboxaldehyde)thiocarbonohydrazone

Antitumor Comparison of Three α-N-Heterocyclic Thiosemicarbazone Derivatives' Crystal Structures of Bis(2-acetylpyridine)thiocarbonohydrazone and Bis(imidazole-2-carboxaldehyde)thiocarbonohydrazone
暂未订购
导出
摘要 A series of ligands,HL1(2-acetylpyridine thiosemicarbazone),H2L2(bis(2-acetyl-pyridine) thiocarbonohydrazone) and H2L3(bis(imidazole-2-carboxaldehyde) thiocarbonohydrazone) was synthesized.H2L2 and H2L3 were characterized by elemental analysis,IR spectra and single-crystal X-ray diffraction studies.Hydrogen bonds link different components to stabilize the crystal structure in the two ligands.To comprehend the structure-activity relationship well,the three ligands are all tested against human K562 leucocythemia cell line with IC50 analysis.Different substituent groups on the ligands show different levels of antitumor activity.By comparison with the other species studied,H2L2 with thiocarbonohydrazone along with 2-acetylpyridine is the most active compound with IC50 = 2.48 μM. A series of ligands,HL1(2-acetylpyridine thiosemicarbazone),H2L2(bis(2-acetyl-pyridine) thiocarbonohydrazone) and H2L3(bis(imidazole-2-carboxaldehyde) thiocarbonohydrazone) was synthesized.H2L2 and H2L3 were characterized by elemental analysis,IR spectra and single-crystal X-ray diffraction studies.Hydrogen bonds link different components to stabilize the crystal structure in the two ligands.To comprehend the structure-activity relationship well,the three ligands are all tested against human K562 leucocythemia cell line with IC50 analysis.Different substituent groups on the ligands show different levels of antitumor activity.By comparison with the other species studied,H2L2 with thiocarbonohydrazone along with 2-acetylpyridine is the most active compound with IC50 = 2.48 μM.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2010年第9期1380-1386,共7页 结构化学(英文)
基金 supported by the Natural Science Foundation of Henan Province,the Natural Science Foundation of Educational Department of Henan Province (2010B150003) China Postdoctoral Science Foundation (20090460847)
关键词 THIOSEMICARBAZONE thiocarbonohydrazone crystal structure cytotoxic activity thiosemicarbazone thiocarbonohydrazone crystal structure cytotoxic activity
  • 相关文献

参考文献28

  • 1Liu, G. F.; Liu, L.; Hu, X.; Jia, D. Z.; Yu, K. B. ChineseJ. Struet. Chem. 2006, 25, 1233-1237.
  • 2Zhang, N. Y.; Li, Q. J.; Liu, Y. Y. Chinesed. Struct. Chem. 2008, 27, 1055-1058.
  • 3Du, X.; Guo, C.; Hansell, E.; Doyle, P. S.; Caffrey, C. R.; Holler, T. P.; McKerrow, L H.; Cohen, F. E. J. Med. Chem. 2002, 45, 2695-2707.
  • 4Kovala-Demertzi, D.; Demertzis, M. A.; Filiou, E.; Pantazaki, A. A.; Yadav, P. N.; Miller, J. R.; Zheng, Y.; Kyriakidis, D. A. Biometals 2003, 16, 411-418.
  • 5Afi'asiabi, Z.; Sinn, E.; Chen, J.; Ma, Y.; Rheingold, A. L.; Zakharov, L. N.; Path, N.; Padhye, S. Inorg. Chim. Acta 2004, 357, 271-278.
  • 6Schelman, W. R.; Morgan-Meadows, S.; Mamocha, R.; Lee, F.; Eickhoff, J.; Huang, W.; Pomplun, M.; Jiang, Z. S.; Alberti, D.; Kolesar, J. M.; Ivy, P.; Wilding, G.; Traynor, A. M. Cancer Chemother. Pharmacol. 2009, 63, 1147-1156.
  • 7Miller III, M. C.; Stineman, C. N.; Vance, J. R.; West, D. X.; Hall, I. H. Anticancer Res. 1998, 18, 4131-4139.
  • 8Kovala-Demcrtzi, D.; Yadav, P. N.; Dcmcrtzis, M. A.; Coluccia, M. J. Inorg. Biochem. 2000, 78, 347-354.
  • 9Kovala-Demertzi, D.; Demertzis, M. A.; Miller, J. R.; Papadopoulou, C.; Dodorou, C.; Filousis, G. J. Inorg. Biochem. 2001, 86, 555-563.
  • 10Kovala-Demertzi, D.; Domopoulou, A.; Demertzis, M. A.; Papageorgiou, A.; West, D. X. Polyhedron 1997, 16, 3625-3633.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部